Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dabigatran Etexilate. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Dabigatran etexilate.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Dabigatran etexilate.
Level 2 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Dabigatran etexilate.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Dabigatran etexilate.
Level 2 evidence
Abrocitinib
The serum concentration of Dabigatran etexilate can be increased when it is combined with Abrocitinib.
Level 1 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Dabigatran etexilate is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Dabigatran etexilate.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Dabigatran etexilate.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Dabigatran etexilate.
Level 2 evidence
Aceclofenac
The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Dabigatran etexilate.
Level 1 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Dabigatran etexilate.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Dabigatran etexilate.
Level 2 evidence
Enter your NPI to unlock 13 major interactions for Dabigatran Etexilate
Dabigatran Etexilate has 1212 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Dabigatran Etexilate has 76 major, 924 moderate, and 212 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dabigatran Etexilate. Always confirm against the full prescribing information.